CGC
CGC
NASDAQ · Pharmaceuticals

Canopy Growth Corp

$0.95
+0.03 (+2.92%)
As of Sep 22, 2:41 PM ET ·
Financial Highlights (FY 2026)
Revenue
555.82M
Net Income
-513,445,929
Gross Margin
27.9%
Profit Margin
-92.4%
Rev Growth
-10.9%
D/E Ratio
0.35
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 27.9% 27.9% 56.1% 56.1%
Operating Margin -61.9% -55.7% 13.1% 13.7%
Profit Margin -92.4% -87.8% 14.3% 14.3%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 555.82M 624.10M 156.52M 143.27M
Gross Profit 155.35M 174.44M 87.74M 80.31M
Operating Income -344,219,814 -347,852,944 20.57M 19.56M
Net Income -513,445,929 -518,865,187 22.40M 20.41M
Gross Margin 27.9% 27.9% 56.1% 56.1%
Operating Margin -61.9% -55.7% 13.1% 13.7%
Profit Margin -92.4% -87.8% 14.3% 14.3%
Rev Growth -10.9% -10.9% +1.7% +0.2%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 70.78M 70.78M 105.38M 93.00M
Total Equity 200.73M 200.73M 454.44M 415.12M
D/E Ratio 0.35 0.35 0.23 0.22
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -305,471,515 -325,845,429 28.04M 26.75M
Free Cash Flow 15.05M 13.14M